MONOPHARMA
Start SIP
Invest Now
Start SIP in MONOPHARMA
Performance
- Low
- ₹15
- High
- ₹15
- 52 Week Low
- ₹15
- 52 Week High
- ₹35
- Open Price₹15
- Previous Close₹15
- Volume2,000
Investment Returns
- Over 1 Month -34.24%
- Over 3 Month -34.24%
- Over 6 Month -43.47%
- Over 1 Year -58.15%
Smart Investing Starts Here Start SIP with Mono Pharmacare for Steady Growth!
Mono Pharmacare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 8.2
- PEG Ratio
- -
- Market Cap Cr
- 26
- P/B Ratio
- 0.8
- Average True Range
- 0.84
- EPS
- 1.75
- Dividend Yield
- 0
- MACD Signal
- -1.37
- RSI
- 28.63
- MFI
- 24.85
Mono Pharmacare Financials
Mono Pharmacare Technicals
EMA & SMA
Current Price
₹14.50
-0.7
(-4.61%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹17.24
- 50 Day
- ₹19.53
- 100 Day
- ₹21.83
- 200 Day
- ₹26.00
Resistance and Support
14.5
- R3 14.50
- R2 14.50
- R1 14.50
- S1 14.50
- S2 14.50
- S3 14.50
Mono Pharmacare Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-29 | Quarterly Results & Others | To consider other business matters (Revised) |
| 2025-08-26 | Others | To consider other business matters |
| 2025-05-30 | Audited Results & Others | (Revised) To consider other business matters. |
| 2025-04-11 | Others | To consider other business matters (Revised) |
| 2025-02-10 | Others | To consider other business matters |
Mono Pharmacare F&O
About Mono Pharmacare
- NSE Symbol
- MONOPHARMA
- BSE Symbol
- Managing Director
- Mr. Panilam Lakhatariya
- ISIN
- INE0OIP01012
Similar Stocks to Mono Pharmacare
Mono Pharmacare FAQs
Mono Pharmacare share price is ₹14 As on 02 January, 2026 | 03:21
The Market Cap of Mono Pharmacare is ₹25.6 Cr As on 02 January, 2026 | 03:21
The P/E ratio of Mono Pharmacare is 8.2 As on 02 January, 2026 | 03:21
The PB ratio of Mono Pharmacare is 0.8 As on 02 January, 2026 | 03:21
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.